Buscar resultados de ensayos clínicos

Patrocinado por

Purpura - 88 Studies Found

Estado Estudiar
Completed Nombre del estudio: SB-497115 (Oral Thrombopoietin Receptor Agonist) Versus Placebo In Adults With Refractory Immune Thrombocytopenic Purpura (ITP)
Condición: Purpura, Thrombocytopaenic, Idiopathic
Fecha: 2005-02-01
Intervenciones: Drug: SB497115
Completed Nombre del estudio: High-dose Dexamethasone Versus Conventional Dose Prednisone for Initial Treatment of Primary Immune Thrombocytopenia (ITP)
Condición: Purpura, Thrombocytopenic, Idiopathic
Fecha: 2011-05-17
Intervenciones:
  • Drug: Prednisone Prednisone, p
Withdrawn Nombre del estudio: A Study to Investigate Belimumab for the Treatment of Chronic Immune Thrombocytopenia.
Condición: Purpura, Thrombocytopaenic, Idiopathic
Fecha: 2011-09-22
Intervenciones:
  • Drug: Belimumab 10 mg /kg give
Completed Nombre del estudio: Daily Prednisone Versus Pulsed Dexamethasone in Treatment-naïve Adult Patients With Immune Thrombocytopenia
Condición: Purpura, Thrombocytopenic, Idiopathic
Fecha: 2015-01-06
Intervenciones:
  • Drug: Prednisone
  • Drug: Dexamethasone
Withdrawn Nombre del estudio: Recombinant Human Interleukin-11 Combination Low-dose Rituximab in Immune Thrombocytopenia
Condición: Purpura, Thrombocytopenic, Idiopathic
Fecha: 2011-03-17
Intervenciones: Drug: rhIL-11 Recombinant Human Interleukin-11 (rhIL-11) Combinating Low-dose Rituximab
Completed Nombre del estudio: The ITP-RITUX Cohort: Rituximab in Immune ThrombocytoPenia.
Condición:
  • Purpura, Thrombocytopenic, Idiopathic
  • Aut
    Fecha: 2010-04-05
Withdrawn Nombre del estudio: Prophylactic Plasma Infusion Therapy for Congenital Thrombotic Thrombocytopenic Purpura
Condición: Purpura, Thrombotic Thrombocytopenic
Fecha: 2012-12-12
Intervenciones:
  • Drug: Octaplas infusion and placebo (group 1)

Terminated Nombre del estudio: IdeS in Asymptomatic Asymptomatic Antibody-Mediated Thrombotic Thrombocytopenic Purpura (TTP) Patients
Condición: Purpura, Thrombotic Thrombocytopenic
Fecha: 2016-07-27
Intervenciones: Biological: HMed-IdeS One dose of 0.25 mg/kg BW HMed-IdeS on study day 0. Following and evaluation of ef
Completed Nombre del estudio: Rituximab in Adult Acquired Idiopathic Thrombotic Thrombocytopenic Purpura
Condición: Thrombotic Thrombocytopenic Purpura
Fecha: 2009-05-22
Intervenciones: Drug: rituximab Patients will be treated according to the recommendations of the Reference Centre for th
Active, not recruiting Nombre del estudio: Study of Cyclosporine or Corticosteroids as an Adjunct to Plasma Exchange in Thrombotic Thrombocytopenic Purpura (TTP)
Condición: Thrombotic Thrombocytopenic Purpura
Fecha: 2008-07-09
Intervenciones:
  • Drug: Cyclosporine 2-3 mg/kg o
<<< Previous | Next >>>